NCT00687505 2021-12-13Safety Study of FP-1039 To Treat CancerFive Prime Therapeutics, Inc.Phase 1 Completed39 enrolled
NCT01868022 2019-08-19Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway SignalingGlaxoSmithKlinePhase 1 Completed65 enrolled 32 charts